3.0.0 3912 2022-11-01T13:50:26Z 2022-11-01T13:50:26Z House HR 2019-07-23 116 [Congressional Record Volume 165, Number 124 (Tuesday, July 23, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. LEWIS:H.R. 3912.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I of the United States Constitutionand its subsequent amendments, and further clarified andinterpreted by the Supreme Court of the United States.[Page H7243]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2019-07-24T17:42:28Z Referred to 2019-07-23T16:04:15Z hswm00 Ways and Means Committee House Standing hswm02 Health Subcommittee Referred to 2019-07-23T19:00:16Z Referred to 2019-07-23T16:04:20Z Chronic Kidney Disease Improvement in Research and Treatment Act of 2019 116 1676 S 2019-05-23 Read twice and referred to the Committee on Finance. Related bill CRS Jack Reynold’s Memory MediGap Expansion 116 8181 HR 2020-09-08 Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Related bill CRS 2019-07-24 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-07-23 hswm02 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-07-23 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2019-07-23 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-07-23 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-07-23 Introduced in House IntroReferral 1000 9 Library of Congress L000287 Rep. Lewis, John [D-GA-5] JOHN LEWIS D GA 5 N B001260 Rep. Buchanan, Vern [R-FL-16] Vern Buchanan R FL 16 2019-07-23 True F000466 Rep. Fitzpatrick, Brian K. [R-PA-1] Brian Fitzpatrick R PA K. 1 2019-07-25 False P000604 Rep. Payne, Donald M., Jr. [D-NJ-10] Donald Payne D NJ M. 10 2019-10-08 False M001188 Rep. Meng, Grace [D-NY-6] Grace Meng D NY 6 2019-12-05 False L000551 Rep. Lee, Barbara [D-CA-13] BARBARA LEE D CA 13 2020-06-15 False Health Administrative law and regulatory procedures Aging Congressional oversight Debt collection Department of Health and Human Services Digestive and metabolic diseases Drug therapy Government studies and investigations Health care costs and insurance Health care coverage and access Health care quality Health facilities and institutions Health information and medical records Health personnel Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Hospital care Long-term, rehabilitative, and terminal care Medical education Medical research Medicare National and community service Performance measurement Student aid and college costs Health 00 2019-07-23 Introduced in House 2020-12-01T20:04:48Z Chronic Kidney Disease Improvement in Research and Treatment Act

This bill expands, establishes, and otherwise modifies requirements under Medicare and other health care programs relating to individuals with end-stage renal disease (ESRD).

Among other things, the bill

  • expands the scope of the National Health Service Corps to specifically include kidney disease specialists,
  • modifies payments under the Medicare ESRD program to exclude certain adjustment factors (e.g., comorbidities),
  • authorizes incentive payments for renal dialysis facilities that exceed performance standards under the Medicare ESRD program, and
  • expands guaranteed issue rights with respect to Medigap policies (Medicare supplemental health insurance policies) to all ESRD beneficiaries.
]]> Chronic Kidney Disease Improvement in Research and Treatment Act Display Title Chronic Kidney Disease Improvement in Research and Treatment Act Official Title as Introduced To amend title XVIII of the Social Security Act to increase awareness, expand preventative services, and improve care for individuals with end-stage renal disease, and for other purposes. Introduced in House IH Short Title(s) as Introduced Chronic Kidney Disease Improvement in Research and Treatment Act Introduced in House IH Introduced in House 2019-07-23T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr3912ih/xml/BILLS-116hr3912ih.xml 2019-07-24 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.